These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 137687)

  • 1. [145 cases of toxidermatoses. Clinical, histologic and immunologic study].
    Saurat JH; Puissant A; Tilles G; Noury-Duperrat G; Duperrat B
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):666-9. PubMed ID: 137687
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous drug eruptions: a 5-year experience.
    Gerson D; Sriganeshan V; Alexis JB
    J Am Acad Dermatol; 2008 Dec; 59(6):995-9. PubMed ID: 19022101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug eruptions: a review of clinical and immunological features.
    Kalish RS
    Adv Dermatol; 1991; 6():221-37; discussion 238. PubMed ID: 1824566
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct immunofluorescence for the study of cutaneous drug eruptions.
    Gibson LE; van Hale HM; Schroeter AL
    Acta Derm Venereol; 1986; 66(1):39-44. PubMed ID: 2424213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced lupus secondary to sertraline.
    Hussain HM; Zakaria M
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1074-5. PubMed ID: 19031644
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent.
    Jaber SH; Cowen EW; Haworth LR; Booher SL; Berman DM; Rosenberg SA; Hwang ST
    Arch Dermatol; 2006 Feb; 142(2):166-72. PubMed ID: 16490844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lichenoid eruptions after gold therapy. Report of two cases].
    Lasarowa AZ; Tsankov NK; Stoimenov AP
    Hautarzt; 1992 Aug; 43(8):514-6. PubMed ID: 1387122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequencies of Th17 cells in drug eruptions.
    Fujiyama T; Kawakami C; Sugita K; Kubo-Kabashima R; Sawada Y; Hino R; Nakamura M; Shimauchi T; Ito T; Kabashima K; Hashizume H; Tokura Y
    J Dermatol Sci; 2014 Jan; 73(1):85-8. PubMed ID: 24035443
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical and histopathologic spectrum of "dermal hypersensitivity reactions," a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a "dermal hypersensitivity reaction pattern".
    Fung MA
    J Am Acad Dermatol; 2002 Dec; 47(6):898-907. PubMed ID: 12451376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug eruptions (a series of 148 cases).
    Arora PN; Aggarwal SK; Ramakrishnan KR; Chattopadhyay SP
    Indian J Dermatol; 1989 Dec; 34(4):75-80. PubMed ID: 2535016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear-macrophages are predominantly classically activated in aminopenicillin-induced maculopapular rashes.
    Treudler R; Tebbe B; Mielcarek K; Goerdt S; Orfanos CE
    Arch Dermatol Res; 2002 Aug; 294(6):290-2. PubMed ID: 12192494
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunocompetent cells of fixed drug eruption.
    Visa K; Käyhkö K; Stubb S; Reitamo S
    Acta Derm Venereol; 1987; 67(1):30-5. PubMed ID: 2436411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous side effects of gold therapy. Clinical and histologic results].
    Hofmann C; Burg G; Jung C
    Z Rheumatol; 1986; 45(3):100-6. PubMed ID: 2944308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical characterization of cutaneous drug eruptions by STI571.
    Park HJ; Kim HS; Kim HJ; Lee JY; Cho BK; Lee AW; Yoon DY; Cho DH
    J Dermatol Sci; 2005 Apr; 38(1):9-15. PubMed ID: 15795119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta injection site reaction: review of the histology and report of a lupus-like pattern.
    Conroy M; Sewell L; Miller OF; Ferringer T
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S48-9. PubMed ID: 18625386
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
    Adachi A; Nagai H; Horikawa T
    Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug eruption and related dermal changes].
    Watanabe T
    Rinsho Byori; 1973 May; 21(5):429-34. PubMed ID: 4274099
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal bleomycin injections into normal human skin. A histopathologic and immunopathologic study.
    Templeton SF; Solomon AR; Swerlick RA
    Arch Dermatol; 1994 May; 130(5):577-83. PubMed ID: 7513985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The causes of fixed drug eruption.
    Puavilai S; Timpatanapong P; Tasanapradit P; Polnikorn N; Charuwichitratana S; Sugkraroek S
    J Med Assoc Thai; 1984 Nov; 67(11):591-5. PubMed ID: 6241225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.